EUVIMEDEUVIMED entdecken
Crossref

SRS355 - Sarcopenia and outcomes in retroperitoneal and intra-abdominal sarcoma: a 10-year retrospective study

Nadhirah Kahar, Lewis Goulder, Ahmed Al-Mukhtar

British Journal of Surgery · 27.03.2026 · 113 (Supplement_2)

DOI: 10.1093/bjs/znag018.315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 27.03.2026. Verfasst von Nadhirah Kahar und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Assessment of sarcopenia has emerged as a prognostic indicator in several malignancies, including lung cancer, resectable colorectal cancer, and urological cancer (Suzuki et al., 2016; Yang et al., 2019; Li et al., 2019). These findings suggest sarcopenia may also serve as a prognostic marker in patients with retroperitoneal sarcoma, but evidence in this population is limited.

Methods

A retrospective analysis was conducted on patients diagnosed with sarcoma at a single trust over ten years (2014–2024). Psoas Muscle Index (PMI) was calculated from cross-sectional computed tomography (CT) imaging. Published PMI cut-offs (524 mm²/m² for males and 385 mm²/m² for females; Prado et al., 2008) were applied to identify sarcopenic patients. Mortality and cancer recurrence were the primary outcomes. To explore whether cohort-specific thresholds better predicted outcomes, sex-specific PMI cut-offs were also derived using receiver operating characteristic (ROC) analysis and Youden’s J statistic.

Results

Of 145 patients diagnosed with retroperitoneal or intra-abdominal sarcoma, six were excluded due to missing data, leaving 139 for analysis. 42 patients (30.2%) were sarcopenic and 97 (69.8%) non-sarcopenic. Mortality did not significantly differ between groups (23.8% versus 24.7%). Application of ROC/Youden’s J-derived thresholds did not meaningfully alter these findings. Recurrence rates were comparable (4.8% versus 3.1%).

Discussion

In this cohort, sarcopenia defined by PMI was not associated with increased mortality or recurrence in patients with retroperitoneal or intra-abdominal sarcoma. Further research incorporating more robust measures of skeletal muscle mass and function is required to clarify its prognostic value in this population.

Zitieren

APA

Kahar, N., Goulder, L., & Al-Mukhtar, A. (2026). SRS355 - Sarcopenia and outcomes in retroperitoneal and intra-abdominal sarcoma: a 10-year retrospective study. British Journal of Surgery, 113(Supplement_2). https://doi.org/10.1093/bjs/znag018.315

Vancouver

Kahar N, Goulder L, Al-Mukhtar A. SRS355 - Sarcopenia and outcomes in retroperitoneal and intra-abdominal sarcoma: a 10-year retrospective study. British Journal of Surgery. 2026;113(Supplement_2). doi:10.1093/bjs/znag018.315

BibTeX
@article{Kahar2026,
  author = {Kahar, Nadhirah and Goulder, Lewis and Al-Mukhtar, Ahmed},
  title = {SRS355 - Sarcopenia and outcomes in retroperitoneal and intra-abdominal sarcoma: a 10-year retrospective study},
  journal = {British Journal of Surgery},
  year = {2026},
  volume = {113},
  number = {Supplement_2},
  doi = {10.1093/bjs/znag018.315}
}
Kostenlos starten →